Published in J Biol Inorg Chem on July 09, 2003
A potent cytotoxic photoactivated platinum complex. Proc Natl Acad Sci U S A (2007) 1.21
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs. Chem Rev (2016) 1.02
Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design. Adv Inorg Chem (2009) 1.01
Unusual DNA binding modes for metal anticancer complexes. Biochimie (2009) 0.95
Photoinduced reactions of cis,trans,cis-[Pt(IV)(N3)2(OH)2(NH3)2) with 1-methylimidazole. Chemistry (2009) 0.89
Comparison of the electronic properties, and thermodynamic and kinetic parameters of the aquation of selected platinum(II) derivatives with their anticancer IC50 indexes. J Mol Model (2008) 0.81
Pt-bridges in various single-strand and double-helix DNA sequences. DFT and MP2 study of the cisplatin coordination with guanine, adenine, and cytosine. J Mol Model (2006) 0.76
Investigations of the binding of [Pt2(DTBPA)Cl2](II) and [Pt2(TPXA)Cl2](II) to DNA via various cross-linking modes. Int J Mol Sci (2013) 0.75
Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem Rev (1999) 5.63
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry (1985) 3.67
The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacol Ther (1987) 2.96
Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol (1990) 2.60
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA. Biochemistry (1986) 2.09
Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II). Biochemistry (1983) 1.96
Interstrand cross-links are preferentially formed at the d(GC) sites in the reaction between cis-diamminedichloroplatinum (II) and DNA. Proc Natl Acad Sci U S A (1991) 1.79
DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues. Proc Natl Acad Sci U S A (1993) 1.65
Nucleotide cross-linking induced by photoreactions of platinum(IV)-azide complexes. Angew Chem Int Ed Engl (2003) 0.92
Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking. Biochemistry (1999) 0.89
DNA interactions of bifunctional dinuclear platinum(II) antitumor agents. Eur J Biochem (1997) 0.88
Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro. J Med Chem (1996) 0.78
Photolysis of an iodoplatinum(IV) diamine complex to cytotoxic species by visible light. Anticancer Drug Des (1996) 0.78
Protein recognition of macrocycles: binding of anti-HIV metallocyclams to lysozyme. Proc Natl Acad Sci U S A (2005) 2.31
New trends for metal complexes with anticancer activity. Curr Opin Chem Biol (2008) 2.06
A potent trans-diimine platinum anticancer complex photoactivated by visible light. Angew Chem Int Ed Engl (2010) 1.74
A novel protein-mineral interface. Nat Struct Biol (2003) 1.69
Optically pure, water-stable metallo-helical 'flexicate' assemblies with antibiotic activity. Nat Chem (2011) 1.61
Periodic iron nanomineralization in human serum transferrin fibrils. Angew Chem Int Ed Engl (2008) 1.52
Metal complexes as DNA intercalators. Acc Chem Res (2011) 1.47
Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. Drug Discov Today (2009) 1.47
Organometallic half-sandwich iridium anticancer complexes. J Med Chem (2011) 1.40
Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity. Inorg Chem (2007) 1.40
Ligand-selective photodissociation from [Ru(bpy)(4AP)4]2+: a spectroscopic and computational study. Inorg Chem (2009) 1.35
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. Chem Commun (Camb) (2005) 1.34
Zinc(II) complexes of constrained antiviral macrocycles. Dalton Trans (2012) 1.28
DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair. J Biol Chem (2002) 1.28
Structure and dynamics of metallomacrocycles: recognition of zinc xylyl-bicyclam by an HIV coreceptor. J Am Chem Soc (2002) 1.26
Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts. J Am Chem Soc (2002) 1.26
DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media. Biochemistry (2003) 1.25
Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities. Biochem J (2004) 1.24
Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity. Inorg Chem (2006) 1.22
Mechanism of the formation of DNA-protein cross-links by antitumor cisplatin. Nucleic Acids Res (2007) 1.22
A potent cytotoxic photoactivated platinum complex. Proc Natl Acad Sci U S A (2007) 1.21
Exploration of the medical periodic table: towards new targets. Chem Commun (Camb) (2013) 1.18
Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms. J Am Chem Soc (2003) 1.18
How to modify 7-azaindole to form cytotoxic Pt(II) complexes: highly in vitro anticancer effective cisplatin derivatives involving halogeno-substituted 7-azaindole. J Inorg Biochem (2012) 1.17
Combined theoretical and computational study of interstrand DNA guanine-guanine cross-linking by trans-[Pt(pyridine)2] derived from the photoactivated prodrug trans,trans,trans-[Pt(N3)2(OH)2(pyridine)2]. Inorg Chem (2012) 1.11
Configurationally restricted bismacrocyclic CXCR4 receptor antagonists. J Med Chem (2006) 1.10
Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents. Chem Asian J (2008) 1.10
Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine. Dalton Trans (2009) 1.10
Multiple bacteria encode metallothioneins and SmtA-like zinc fingers. Mol Microbiol (2002) 1.09
Kinetics of aquation and anation of ruthenium(II) arene anticancer complexes, acidity and X-ray structures of aqua adducts. Chemistry (2003) 1.09
Interdomain zinc site on human albumin. Proc Natl Acad Sci U S A (2003) 1.08
Synergistic anion and metal binding to the ferric ion-binding protein from Neisseria gonorrhoeae. J Biol Chem (2002) 1.08
Photoactivatable platinum complexes. Anticancer Agents Med Chem (2007) 1.08
Cyclam complexes and their applications in medicine. Chem Soc Rev (2004) 1.07
DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes. Nucleic Acids Res (2003) 1.06
Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands. J Med Chem (2006) 1.06
A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin. Chemistry (2006) 1.05
Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers. Proc Natl Acad Sci U S A (2003) 1.04
A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464. J Biol Inorg Chem (2002) 1.04
Anti-viral cyclam macrocycles : rapid zinc uptake at physiological pH. Chem Commun (Camb) (2004) 1.03
Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem Soc Trans (2008) 1.02
Configurations of nickel-cyclam antiviral complexes and protein recognition. Chemistry (2007) 1.02
Role of Tyr84 in controlling the reactivity of Cys34 of human albumin. FEBS J (2005) 1.02
Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design. Adv Inorg Chem (2009) 1.01
Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. J Am Chem Soc (2006) 1.01
Designing organometallic compounds for catalysis and therapy. Chem Commun (Camb) (2012) 1.00
Photoactivatable metal complexes: from theory to applications in biotechnology and medicine. Philos Trans A Math Phys Eng Sci (2013) 1.00
Osmium(II) and ruthenium(II) arene maltolato complexes: rapid hydrolysis and nucleobase binding. Chemistry (2007) 1.00
DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines. Biochemistry (2003) 1.00
Recognition of major DNA adducts of enantiomeric cisplatin analogs by HMG box proteins and nucleotide excision repair of these adducts. Chem Biol (2002) 1.00
Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity. Proc Natl Acad Sci U S A (2005) 1.00
Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity. Chem Biol (2005) 0.98
DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts. Biochemistry (2003) 0.97
Next-generation metal anticancer complexes: multitargeting via redox modulation. Inorg Chem (2013) 0.97
Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands. J Med Chem (2007) 0.97
Insights into how nucleotide-binding domains power ABC transport. Structure (2009) 0.97
Unusual DNA binding modes for metal anticancer complexes. Biochimie (2009) 0.95
Catalytic organometallic anticancer complexes. Proc Natl Acad Sci U S A (2008) 0.95
Trifunctional dinuclear platinum complexes as DNA-protein cross-linking agents. Biochemistry (2004) 0.95
Organoiridium complexes: anticancer agents and catalysts. Acc Chem Res (2014) 0.95
Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes. Inorg Chem (2011) 0.95
Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair. Mol Pharm (2011) 0.95
Organometallic ruthenium and iridium transfer-hydrogenation catalysts using coenzyme NADH as a cofactor. Angew Chem Int Ed Engl (2012) 0.94
Light-activated destruction of cancer cell nuclei by platinum diazide complexes. Chem Biol (2006) 0.94
Isomer separation and gas-phase configurations of organoruthenium anticancer complexes: ion mobility mass spectrometry and modeling. J Am Soc Mass Spectrom (2009) 0.93
Unprecedented carbon-carbon bond formation induced by photoactivation of a platinum(IV)-diazido complex. Chem Commun (Camb) (2007) 0.93
Photoreaction pathways for the anticancer complex trans,trans,trans-[Pt(N3)2(OH)2(NH3)2]. Dalton Trans (2010) 0.92
Nucleotide cross-linking induced by photoreactions of platinum(IV)-azide complexes. Angew Chem Int Ed Engl (2003) 0.92
Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog. Biophys J (2007) 0.92
Competitive reactions of a ruthenium arene anticancer complex with histidine, cytochrome c and an oligonucleotide. J Biol Inorg Chem (2005) 0.92
Factors affecting DNA-DNA interstrand cross-links in the antiparallel 3'-3' sense: a comparison with the 5'-5' directional isomer. Chemistry (2009) 0.92
Photocontrolled DNA binding of a receptor-targeted organometallic ruthenium(II) complex. J Am Chem Soc (2011) 0.92
Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 protein. Biochemistry (2003) 0.91
Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts. Chemistry (2013) 0.91
Oxo-iron clusters in a bacterial iron-trafficking protein: new roles for a conserved motif. Biochem J (2003) 0.91
DNA condensing effects and sequence selectivity of DNA binding of antitumor noncovalent polynuclear platinum complexes. Inorg Chem (2014) 0.91
Amide-based prodrugs of spermidine-bridged dinuclear platinum. Synthesis, DNA binding, and biological activity. J Med Chem (2008) 0.90
Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity. J Am Chem Soc (2007) 0.90
Selective recognition of configurational substates of zinc cyclam by carboxylates: implications for the design and mechanism of action of anti-HIV agents. Chemistry (2003) 0.90
Use of top-down and bottom-up Fourier transform ion cyclotron resonance mass spectrometry for mapping calmodulin sites modified by platinum anticancer drugs. Anal Chem (2011) 0.90
Conformation, protein recognition and repair of DNA interstrand and intrastrand cross-links of antitumor trans-[PtCl2(NH3)(thiazole)]. Nucleic Acids Res (2005) 0.90
Photoinduced reactions of cis,trans,cis-[Pt(IV)(N3)2(OH)2(NH3)2) with 1-methylimidazole. Chemistry (2009) 0.89
Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles. Biochem Pharmacol (2009) 0.89
A novel copper site in a cyanobacterial metallochaperone. Biochem J (2004) 0.89
Recognition of DNA three-way junctions by metallosupramolecular cylinders: gel electrophoresis studies. Chemistry (2007) 0.89
Interactions of DNA with a new platinum(IV) azide dipyridine complex activated by UVA and visible light: relationship to toxicity in tumor cells. Chem Res Toxicol (2012) 0.88
Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes. Chemistry (2004) 0.88